Disrupting the Dok3–Card9 Interaction with Synthetic Peptides Enhances Antifungal Effector Functions of Human Neutrophils

Bibliographic Details
Title: Disrupting the Dok3–Card9 Interaction with Synthetic Peptides Enhances Antifungal Effector Functions of Human Neutrophils
Authors: Jia Tong Loh, Joey Kay Hui Teo, Srinivasaraghavan Kannan, Chandra S. Verma, Hong-Hwa Lim, Kong-Peng Lam
Source: Pharmaceutics, Vol 15, Iss 7, p 1780 (2023)
Publisher Information: MDPI AG, 2023.
Publication Year: 2023
Collection: LCC:Pharmacy and materia medica
Subject Terms: neutrophils, antifungal immunity, Dok3, Card9, interference peptide, Pharmacy and materia medica, RS1-441
More Details: Invasive fungal disease is an emerging and serious public health threat globally. The expanding population of susceptible individuals, together with the rapid emergence of multidrug-resistant fungi pathogens, call for the development of novel therapeutic strategies beyond the limited repertoire of licensed antifungal drugs. Card9 is a critical signaling molecule involved in antifungal defense; we have previously identified Dok3 to be a key negative regulator of Card9 activity in neutrophils. In this study, we identified two synthetic peptides derived from the coiled-coil domain of Card9, which can specifically block Dok3–Card9 binding. We showed that these peptides are cell-permeable, non-toxic, and can enhance antifungal cytokine production and the phagocytosis of human neutrophils upon fungal infection. Collectively, these data provide a proof of concept that disrupting the Dok3–Card9 interaction can boost the antifungal effector functions of neutrophils; they further suggest the potential utility of these peptide inhibitors as an immune-based therapeutic to fight fungal infection.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1999-4923
Relation: https://www.mdpi.com/1999-4923/15/7/1780; https://doaj.org/toc/1999-4923
DOI: 10.3390/pharmaceutics15071780
Access URL: https://doaj.org/article/77b5935a20fd4500a7a3b5e138363e74
Accession Number: edsdoj.77b5935a20fd4500a7a3b5e138363e74
Database: Directory of Open Access Journals
Full text is not displayed to guests.
More Details
ISSN:19994923
DOI:10.3390/pharmaceutics15071780
Published in:Pharmaceutics
Language:English